Nomura upgraded Raffles Medical Group to Buy from Neutral with an unchanged price target of S$1.60. The analyst sees the company benefiting from an increase in local and foreign patients in its Singapore hospitals.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>